<DOC>
	<DOCNO>NCT01955044</DOCNO>
	<brief_summary>The purpose study determine buccal administration concentrate formulation long-chain polyunsaturated fatty acid ( LCPUFA ) help maintain docosahexaenoic acid ( DHA ) level extremely low birth weight ( ELBW ) infant .</brief_summary>
	<brief_title>PUFA Supplementation Premature Infants</brief_title>
	<detailed_description>This multi-center , randomize , placebo control , double blind trial . Two dos PUFA compare placebo- `` high '' dose `` low '' dose . ELBW infant enrol study .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Birth Weight</mesh_term>
	<criteria>) Premature infant bear gestational age le 34 week b ) Birth weight less 1000 gram c ) Legally authorize representative able provide write informed consent within first 72 hour life , prior performance protocolspecified evaluation procedure ) infant know metabolic disorder b ) infant know congenital gastrointestinal anomaly c ) infant deem inappropriate enrollment per attend neonatologist</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>72 Hours</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>neonatal prematurity</keyword>
	<keyword>infant , extremely low birth weight</keyword>
	<keyword>fatty acid , polyunsaturated</keyword>
</DOC>